Monovision for the Treatment of Diplopia

Mount Sinai Hospital, Canada

Status and phase: Completed; Phase 1

Conditions: Strabismic Deviation

Treatments: Other: Monovision Correction (with the help of glasses or contact lenses)

Study type: Interventional

Funder types: Other

Identifiers

NCT01426672

08-0289-EMargolin

Details and patient eligibility

About

PURPOSE:

The purpose of this study is to quantitatively assess the efficacy of monovision correction in the treatment of acquired small angle binocular diplopia in adult patients.

METHOD:

Twenty patients with symptomatic diplopia were enrolled in a prospective treatment trial. All had stable deviations of 10 prism diopters or less for over three months. Each received monovision spectacles and/ or contact lenses with distance correction in the dominant eye. Half received a +3.00 diopter (D) add and the others received +2.50 D. The validated and standardized Diplopia Questionnaire and Amblyopia and Strabismus Questionnaire (ASQE) were used to quantify the efficacy of monovision correction for diplopia by measuring the functional impact on vision-specific quality of life.

Enrollment: 20 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Strabismic Deviation less than 12 Prism Diopters

Exclusion criteria

• Inability to sign informed consent

Trial design

20 participants in 1 patient group

Monovision Correctoin

Experimental group

Description:

Monovision correction

Treatment:

Other: Monovision Correction (with the help of glasses or contact lenses)